Novartis halts pursuit of Cytokinetics acquisition, impacting promising heart drug. Analysts estimate $3.6 billion sales for Cytokinetics' cardiomyopathy drug by 2032. Still lead drug aficamten viewed as a distinctive therapy for Hypertrophic Cardiomyopathy.
McDonald's stock's Golden Cross boosts investor confidence. Despite uncertainties, McDonald's strong brand, global presence, and strategic initiatives make it a promising investment.
ABB Ltd announced acquisition of Swiss start-up Sevensense for undisclosed amount. The buyout aims to enhance AI-based navigation and fuel mobile robot market growth.
JPM and BAC report Q4 2023 earnings. JPM stock up 25%, BAC lags. With anticipated rate cuts, investors question value. Analysts see more upside in BAC stock.
CVS Health's strategic pharmacy changes within Target stores. Closures from Feb to Apr due to market dynamics. Prescription transfers to nearby CVS locations.